13,14-dihydroprostaglandin C-type derivatives

Details 13,14-dihydroprostaglandin C-type derivatives 13,14-dihydroprostaglandin C-type derivatives

1988-08-25

1989-12-19

Gerstl, Robert

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514568, 514573, 560 51, 560 53, 560118, 560121, 562459, 562463, 562500, 562503, C07C17700, A61K 31557

Patent

active

048883581

ABSTRACT:
Novel 13,14-dihydroprostaglandin derivatives of the formula ##STR1## wherein: m is 1 or 3;

REFERENCES:
patent: 3872149 (1975-03-01), Crabbe
patent: 3993686 (1986-11-01), Kelly
patent: 4051160 (1977-09-01), Bundy et al.
patent: 4082782 (1978-04-01), Morton, Jr.
patent: 4082789 (1978-04-01), Jones

Affiliated with

Also associated with

Rating

13,14-dihydroprostaglandin C-type derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 13,14-dihydroprostaglandin C-type derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 13,14-dihydroprostaglandin C-type derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1903203